Headquarters and R&D are based in Cambridge UK, with sales operations in the USA and a presence in Germany.  

We develop innovative proprietary algorithms to analyse and interpret real-time physiological signals. Using human-centred design we wrap these algorithms into highly intuitive software with innovative visualisations. 

Our current focus and expertise are in cardiovascular management in anaesthesia and intensive care. 

Hypotension Decision Assist (HDA) has FDA 510(k) Clearance for the US market.